Work

Faculty Opinions recommendation of Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIII.

Year: 2018

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.727123129.793544797

Authors: Valder Arruda, Ben Samelson-Jones

Institutions: University of Pennsylvania, Children's Hospital of Philadelphia

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4252974875

Cites:

Cited by:

Related to: 10